Sequential combined liver-kidney transplantation for a one-year-old boy with infantile primary hyperoxaluria type 1

Japanese Journal of Nephrology

Volumn 48, Issue 1, 2006, Pages 22-28

  Motoyoshi, Yaeko ^a,d   Hattori, Motoshi ^a   Chikamoto, Hiroko ^e   Nakakura, Hyogo ^e   Furue, Takeki ^e   Miyakawa, Sanpei ^e   Kohno, Miyuki ^e   Ito, Katsumi ^e   Kai, Kohtaro ^a   Nakajima, Ichiro ^e   Fuchinoue, Shohei ^e   Teraoka, Satoshi ^e   Akiba, Takashi ^a   Kitayama, Hirotsugu ^b   Wada, Naohiro ^e   Ogawa, Yoshihide ^c  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

^c UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e NONE

Author keywords

Infantile primary hyperoxaluria type 1; Oxalosis; Sequential liver kidney transplantation

Indexed keywords

CALCIUM OXALATE; OXALIC ACID;

ARTICLE; BLOOD LEVEL; CASE REPORT; CHRONIC KIDNEY FAILURE; GROWTH DISORDER; HEMODIAFILTRATION; HUMAN; HYDRATION; INFANT; KIDNEY TRANSPLANTATION; LABORATORY TEST; LIVER TRANSPLANTATION; LIVING DONOR; MALE; OXALOSIS 1; PERITONEAL DIALYSIS; URINE LEVEL;

HUMANS; HYPEROXALURIA, PRIMARY; INFANT; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONORS; MALE; PERITONEAL DIALYSIS;

EID: 33644560313     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Leumann E, Hoppe B. The primary hyperoxaluria. J Am Soc Nephrol 2001; 12: 1896-1993.
2. Fukushima M, Aihara Y, Ichiyama A. Immunochemical studies on induction of rat liver mitochondrial serine: pyruvate amino transferase by glucagon. J Biol Chem 1978; 253: 1187-1194.
3. Nishiyama K, Funai T, Yokota S, Ichiyama A. ATP-dependent degradation of a mutant serine: pyruvate/alanine: glyoxylate aminotransferase in a primary hyperoxaluria type 1 case. J Cell Biol 1993; 123: 1237-1248.
4. Cochat P. Primary hyperoxaluria type 1. Kidney Int 1993; 55: 2533-2547.
5. Cochat P, Koch Nogueira PC, Mahmoud MA, Jamieson NW, Scheinman JL, Rolland MO. Primary hyperoxaluria in infants: medical, ethical, and economic issues. J Pediatr 1999; 135: 746-750.
6. Hoppe B, Langman CB. A United State survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 2003; 18: 986-991.
7. Broyer M, Brunner FP, Brynger H, Dykes SR, Ehrich JHH, Fassbinder W, Geerlings W, Rizzoni G, Selwood NH, Tufveson G, Wing AJ. Kidney transplantation in primary oxalosis: Data from the EDTA registry. Nephrol Dial Transplant 1990; 5: 332-336.
8. Jamieson NV, on behalf of the European PH1 Transplantation Study Group. The European Primary Hyperoxaluria Type 1 Transplant Registry report on the results of combined liver/kidney transplantation for primary hyperoxaluria 1984-1994. Nephrol Dial Transplant 1995; 10(Suppl 8) 33-37.
9. Fuchinoue S, Tanaka K, Nakajima I, Tojinbara T, Fujita S, Kitajima K, Koike T, Abe M, Hoshino T, Nakamura M, Sato S, Tanabe K, Toma H, Shiraga H, Ito K, Hayashi N, Takahashi K, Agishi T. Living related liver transplantation for patients with renal failure. Transplant Proc 1998; 30: 1479-1480.
10. Marangella M, Petrarulo M, Mandolfo S, Vitale C, Cosseddu D, Linari F. Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis. Nephron 1992; 60: 74-80.
11. Hoppe B, Graf D, Offner G, Latta K, Byrd DJ, Michalk D, Brodehl J. Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure. Pediatr Nephrol 1996; 10: 488-492.
12. Yamauchi T, Quillard M, Takahashi S, Nguyen-Khoa M. Oxalate removal by daily dialysis in patient with primary hyperoxaluria type 1. Nephrol Dial Transplant 2001; 16: 2407-2411.
13. Worcester EM, Nakagawa Y, Bushinsky DA, Coe FL. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest 1986; 77: 1888-1896.
14. Marangella M, Cosseddu D, Petrarulo M, Vitale C, Linari F. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria. Nephrol Dial Transplant 1993; 8: 1333-1337.
15. Broyer M, Jouvet P, Niaudet P, Daudon M, Revillon Y. Management of oxalosis. Kidney Int 1996; 49(Suppl 53): S93-S98.
16. Gagnadoux MF, Lacaille F, Niaudet P, Revillon Y, Jouvet P, Jan D, Guest G, Charbit M, Broyer M. Long term results of liver-kidney transplantation in children with primary hyperoxaluria. Pediatr Nephrol 2001; 16: 946-950.
17. Danpure CJ. Primary hyperoxaluria. In: Seriner CR, Sly WS (eds) The Metabolic & Molecular Bases of Inherited Disease, 8th ed. Columbus McGraw-Hill Professional, 2000: 3323-3367.
18. Neville V. Jamieson on behalf of the European PH1 Transplantation Study Group. A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): The European PH1 transplant registry experience 1984-2004. Am J Nephrol 2005; 25: 282-289.